Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety
Abstract Janus kinase (JAK) inhibition is an established therapeutic strategy in rheumatoid arthritis, but heterogeneous treatment responses, persistent safety concerns, and the need for more precise therapeutic positioning continue to stimulate the development of additional JAK-directed compounds. This structured narr...